Various druggable targets such as multiple GPCRs, membrane transporters, SARS - coV - 2 spike protein, CDs, etc.
Epitope mapping to optimize monoclonal antibody and multi-specific antibody design and their mechanism validation
Small Molecular Drug Development
Identification of interactions between small molecule and target proteins to support structure-based drug discovery
Characterization of viruses and virus-like particles and interaction with adjuvants